The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreightons Regulatory News (CRL)

Share Price Information for Creightons (CRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 25.00
Bid: 23.00
Ask: 27.00
Change: 0.00 (0.00%)
Spread: 4.00 (17.391%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 25.00
CRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

22 Nov 2017 07:00

RNS Number : 1435X
Creightons PLC
22 November 2017
 

 

 

For Immediate Release 22 November 2017

 

Creightons plc Group

(the "Group" or "Creightons")

 

Unaudited interim financial report

for the six months ended 30 September 2017

 

 

Financial highlights

 

 

· Revenue increased by 7% £16.7m. (2016: £15.6m).

 

· Operating profit margin of 5.8% (2016 5.1%).

 

· Profit before tax increased by 21% to £956,000 (2016: £790,000).

 

· Diluted EPS 1.09p (2016: 1.00p)

 

· ROCE 10.7% (2016: 9.5%)

 

· Paid final dividend of 0.23p per ordinary share in August 2017 (2016: No dividend).

 

· Interim dividend of 0.15p per ordinary share to be paid in December 2017

 

 

Chairman's statement

 

The Group has continued to make progress in the first half of the year and the impact of the continuing growth can be seen in the results for the period ending 30 September 2017.

 

Sales

Group Sales were £16,734,000 for the six months ended 30 September 2017 (2016: £15,600,000) an increase of 7.3%. This has been achieved in conjunction with an order intake during the period which is 13.5% up on the same period last year. Sales have increased for the period through growth with key existing customers and by bringing on new customers. Sales of our branded products for the first 6 months have exceeded group growth at 12% through existing customers, new export markets and ongoing development of licenced brands. During the period we have focused on winning and extending business with key UK retailers which are growing their personal care and beauty market share as well as a realignment of key contract accounts based on margin performance.

 

Margin and overheads

Our gross margin was 42.1% in the six months to 30 September 2017 (2016: 41.0%). We have continued to benefit from the economies of scale generated by the sales growth in the year to March 2017 and on supplier base consolidation. We intend to focus efforts to improve our margins through targeted investment in plant and machinery which will increase production capacity and improve unit cost of manufacture. This will be key to our success especially in the current economic climate as we continue to see the trend of consumers in the UK focussing on value.

We will continue to manage our overhead cost base and working capital requirements to ensure they are aligned with the anticipated sales levels of the Group, whilst retaining the skills necessary to meet growth opportunities as they arise.

 

Profit before tax

Profit before tax was £956,000 (2016: £790,000), which represents an increase of 21.0%. The increased sales together with the tight control on costs results in an operating profit margin of 5.8% (2016: 5.1%).

 

Tax

It should be noted that the Group utilised all of its historic tax losses in the financial year to 31 March 2017 and therefore we have provided a tax charge within these results of £232,000 (2016: £119,000 - reduced rate due to utilization of historic losses).

 

Earnings per share

I am pleased to report that the impact of the above is a diluted earnings per share of 1.09p (2016: 1.00p) an increase of 9%.

 

Dividend Payments

The Board is pleased to announce that it will be paying an interim dividend of 0.15 pence per ordinary share, reflecting the continued strong performance the group has shown in the first half. I anticipate that this will be paid before Christmas. This is in addition to the dividend of 0.23 pence per ordinary share we paid in August 2017, the charge for which is shown in the accounts to 30 September 2017. The total payment in relation to the dividend paid in August was £139,000 (2016: £0).

 

Working capital and loans

Net cash on hand (cash and cash equivalents less short term borrowings and loans) is a net borrowing of £246,000 (2016: £43,000). The main reason for the decrease in net cash on hand is the higher working capital requirement to support the sales growth during the period.

 

 

The Board and I believe that this half year's sales of £16,734,000 and profit after tax of £724,000 continues to place the Group in a good position to take advantage of any opportunities that may arise.

 

I would like to take this opportunity to thank each and every one of the Group's employees for the hard work and effort they have put in over what has been a challenging period. I would also like to thank our customers, shareholders and suppliers for their support and loyalty to the Group.

 

 

 

W O McIlroy

Executive Chairman 21 November 2017

 

 

 

 

Responsibility statement

 

The names and functions of the Directors of the Company are as follows:

 

William O McIlroy Executive Chairman

Bernard Johnson Executive Managing Director

Mary T Carney Non-executive Director

Nicholas O'Shea Non-executive Director

William Glencross Non-executive Director

Martin Stevens Deputy Managing Director

Pippa Clark Group Sales and Marketing Director

Paul Forster Group Finance and Commercial Director

 

 

The Board confirms that to the best of its knowledge the condensed set of financial statements gives a true and fair view of the assets and liabilities, financial position and profit of the Group and has been prepared in accordance with IAS 34 'Interim Financial Reporting', as adopted by the European Union and that the interim management report includes a fair review of the information required by the Disclosure and Transparency Rules as issued by the Financial Conduct Authority, namely:

· DTR 4.2.7: An indication of important events that have occurred during the first six months of the financial year, and their impact on the condensed set of financial statements, and a description of the principal risks and uncertainties for the remaining six months of the financial year.

· DTR 4.2.8: Details of related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the enterprise during that period. Together with any changes in the related parties transactions described in the last annual report that could have a material effect on the enterprise in the first six months of the current financial year.

By order of the Board

 

 

 

Nicholas O'Shea

Company Secretary and Director 21 November 2017

 

 

 

Principal risks and uncertainties

 

Risks

 

The Board regularly monitors exposure to key risks, such as those related to production efficiencies, cash position and competitive position relating to sales. It has also taken account of the economic situation over the past 12 months, and the impact that has had on costs and consumer purchases.

 

It also monitors those risks not directly or specifically financial, but capable of having a major impact on the business's financial performance if there is any failure, such as product contamination and manufacture outside specification, maintenance of satisfactory levels of customer and consumer service, accident ratios, failure to meet environmental protection standards or any of the areas of regulation mentioned above.

 

Capital structure, cash flow and liquidity

 

The business is funded using retained earnings and invoice discounting, with a bank facility secured against its assets.

 

 

 

Consolidated income statement - unaudited

 

 

Six months ended

30 September (Unaudited)

 

Year ended

31 March (Audited)

2017

2016

2017

Note

£000

£000

£000

 

Revenue

16,734

15,600

30,586

Cost of sales

(9,691)

(9,201)

(17,598)

Gross profit

7,043

6,399

12,988

Distribution costs

(626)

(605)

(1,280)

Administrative expenses

(5,452)

(4,995)

(10,195)

Operating profit

965

799

1,513

Finance costs

(9)

(9)

(24)

Profit before tax

956

790

1,489

Taxation

3

(232)

(119)

(238)

Profit for the period from continuing operations attributable to the equity shareholders of the parent company

724

671

1,251

 

 

Dividend

Six months ended 30 September (Unaudited)

Six months ended 30 September (Unaudited)

Year ended

31 March (Audited)

2017

2016

2017

Dividend Paid in period (£'000)

139

-

-

Paid in period (pence per share)

0.23

-

-

 

 

Earnings per share

 

 

Six months ended 30 September (Unaudited)

Year ended 31 March (Audited)

 

Note

2017

2016

2017

Basic

2

1.20p

1.12p

2.09p

Diluted

2

1.09p

1.00p

1.88p

 

 

 

 

Consolidated statement of comprehensive income - Unaudited

 

Six months ended 30 September (Unaudited)

Year ended 31 March (Audited)

2017

2016

2017

£000

£000

£000

 

Profit for the year

724

671

1,251

 

Exchange differences on translating of foreign operations

-

-

3

Exercise of derivatives

30

-

26

Total comprehensive income for the period attributable to the equity holders of the company

754

671

1,280

 

 

 

Consolidated balance sheet - unaudited

 

 

30 September

31 March

2017

(Unaudited)

2016 (Unaudited)

2017 (Audited)

£000

£000

£000

Non-current assets

Goodwill

331

331

331

Other intangible assets

320

180

212

Property, plant and equipment

1,767

1,582

1,637

2,418

2,093

2,180

Current assets

Inventories

5,736

4,554

4,024

Trade and other receivables

7,901

6,373

4,861

Cash and cash equivalents

213

1,001

2,631

Derivative financial instruments

56

14

19

13,906

11,942

11,535

Total assets

16,324

14,035

13,715

Current liabilities

Trade and other payables

6,618

5,097

4,564

Short term borrowings

459

455

68

Bank loan - under 12 months

-

132

116

Derivative financial instruments

-

40

56

7,077

5,724

4,804

Net current assets

6,829

6,218

6,731

Non-current liabilities

Deferred tax liability

66

-

26

Bank loan

-

457

418

66

457

444

Total liabilities

7,143

6,181

5,248

Net assets

9,181

7,854

8,467

Equity

Share capital

606

599

606

Share premium account

1,260

1,249

1,259

Other reserves

25

25

25

Translation reserve

(9)

(12)

(9)

Cash flow hedge reserve

56

(26)

(37)

Retained earnings

7,243

6,019

6,623

Total equity attributable to the equity shareholders

9,181

7,854

8,467

 

 

Statement of changes in shareholders' equity - unaudited

 

 

Share capital

 

Share premium account

Other reserves

Translation reserve

Cash flow hedge reserve

Retained earnings

Total

£000

£000

£000

£000

£000

£000

£000

Balance at 1 April 2016

599

1,249

25

(12)

(26)

5,307

7,142

Profit for six months ended 30 September 2016

-

-

-

-

-

671

671

Share based payments

-

-

-

-

-

41

41

Exercise of derivatives

-

-

-

-

26

-

26

Charge in relation to derivative financial instruments

-

-

-

-

(26)

-

(26)

Balance at 30 September 2016

599

1,249

25

(12)

(26)

6,019

7,854

 

Profit for six months ended 31 March 2017

-

-

-

-

-

580

580

Share based payments

-

-

-

-

-

49

49

Exchange differences on translation of foreign operations

3

-

-

3

Exercise of options

7

10

-

-

-

-

17

Charge in relation to derivative financial instruments

-

-

-

(11)

-

(11)

Deferred tax through Equity

(25)

(25)

Balance at 31 March 2017

606

1,259

25

(9)

(37)

6,623

8,467

Profit for six months ended 30 September 2017

-

-

-

-

-

724

724

Payment of dividend

-

-

-

-

-

(139)

(139)

Share based payments

-

-

-

-

-

35

35

Exercise of options

-

1

-

-

-

-

1

Exercise of derivatives

-

-

-

-

30

-

30

Charge in relation to derivative financial instruments

-

-

-

-

63

-

63

Balance at 30 September 2017

606

1,260

25

(9)

56

7,243

9,181

 

 

 

 

Consolidated cash flow statement - unaudited

 

Note

Six months ended 30 September (Unaudited)

Year ended

31 March (Audited)

2017

2016

2017

£000

£000

£000

 

Net cash (outflow) / inflow from operating activities

4

(1,532)

(403)

2,058

Cash flow from investing activities

Purchase of property, plant and equipment

(296)

(350)

(551)

Expenditure on intangible assets

(309)

(98)

(306)

Net cash (used in) investing activities

(605)

(448)

(857)

Cash flow from financing activities

Repayment of finance lease obligations

-

(7)

(7)

Proceeds on issue of shares

1

-

17

Payment of dividend

(139)

-

-

(Repayment) / increase of bank loans and invoice finance facilities

(143)

1,044

602

Net cash (used in) / generated from financing activities

(281)

1,037

612

Net (decrease) / increase in cash and cash equivalents

(2,418)

186

1,813

Cash and cash equivalents at start of period

2,631

814

814

Effect of foreign exchange rate changes

-

1

4

Cash and cash equivalents at end of period

213

1,001

2,631

 

 

Notes to the unaudited interim financial report

 

1. Basis of preparation

 

The interim financial statements for the six months ended 30 September 2016 and 30 September 2017 and for the twelve months ended 31 March 2017 do not constitute statutory accounts for the purposes of Section 434 of the Companies Act 2006. The Annual Report and Financial Statements for the year ended 31 March 2017 have been filed with the Registrar of Companies. The Independent Auditors' Report on the Annual Report and Financial Statements for the year ended 31 March 2017 was unqualified, did not draw attention to any matters by way of emphasis, and did not contain a statement under sections 498(2) or 498(3) of the Companies Act 2006. The 30 September 2017 statements were approved by the Board of Directors on 21 November 2017. This unaudited interim report has not been audited or reviewed by auditors pursuant to the Financial Reporting Council guidance on Review of Interim Financial Information.

 

The condensed financial statements in this Interim Report have been prepared in accordance with the requirements of IAS 34 'Interim Financial Reporting' as adopted by the European Union.

 

As required by the Disclosure and Transparency Rules of the UK's Financial Conduct Authority, the condensed set of financial statements has been prepared by applying the accounting policies and presentation that were applied in the preparation on the Company's published consolidated financial statements for the year ended 31 March 2017, which were prepared in accordance with International Financial Reporting Standards as adopted by the European Union.

 

The condensed interim financial statements for the six months ended 30 September 2017 and the comparative figures for the six months ended 30 September 2016 are unaudited. The figures for the year ended 31 March 2017 have been extracted from the Annual Report on which the Auditors issued an unqualified audit report and which have been filed with the Registrar of Companies.

 

2. Earnings per share

 

The calculation of the basic and diluted earnings per share is based on the following data:

 

Six months ended

30 September (Unaudited)

Year ended

31 March (Audited)

2017

2016

2017

£000

£000

£000

Earnings

Net profit attributable to the equity holders of the parent company

724

671

1,251

 

Six months ended

30 September (Unaudited)

Year ended

31 March (Audited)

2017

2016

2017

Number

Number

Number

Number of shares

Weighted average number of ordinary shares for the purposes of basic earnings per share

60,563,551

59,837,243

 59,905,805

Effect of dilutive potential ordinary shares relating to Share options

5,928,689

7,005,000

 6,850,137

Weighted average number of ordinary shares for the purposes of diluted earnings per share

66,492,240

66,842,243

 66,755,942

 

 

3. Taxation

 

Six months ended

30 September (Unaudited)

Year ended

31 March (Audited)

2017

2016

2017

£000

£000

£000

 

Current tax

192

119

237

Deferred tax

40

-

1

Total

232

119

238

 

 

The charge for the period can be reconciled to the profit per the income statement as follows:

 

 

Six months ended

30 September (Unaudited)

Year ended

31 March (Audited)

2017

2016

2017

£000

£000

£000

 

Profit before taxation

956

790

1,489

 

Tax charge at the UK corporation tax rate of 19% (2016 - 20%)

(182)

(158)

(298)

Tax effect of expenses that are not deductible in determining taxable profit

(7)

-

(1)

Deferred tax charge on temporary differences

(1)

-

(1)

Deferred tax credited directly to retained earnings

-

-

25

Adjustment in respect of prior periods

(56)

-

-

Tax effect of utilisation of brought forward tax losses

-

54

54

Adjust closing deferred tax to average rate

(12)

-

5

Adjust opening deferred tax to average rate

(3)

-

1

Deferred tax not recognised

-

-

9

Other differences

29

(15)

(32)

Total expense and effective rate for the year

(232)

(119)

(238)

 

 

4. Notes to cash flow statement

 

Six months ended

30 September (Unaudited)

Year ended 31 March (Audited)

2017

2016

2017

£000

Profit from operations

733

680

1,275

Adjustments for:

Depreciation on property, plant and equipment

166

142

288

Amortisation of intangible assets

201

157

333

Share based payment charge

35

41

90

1,135

1,020

1,986

Increase in inventories

(1,712)

(640)

(112)

Increase in trade and other receivables

(3,040)

(2,324)

(813)

Increase in trade and other payables

2,054

1,551

1,021

Increase in deferred tax provision

40

-

26

Movement in non-cash derivatives

-

-

(26)

Cash (utilised in) / generated from operations

(1,523)

(393)

2,082

Interest (paid)

(9)

(8)

(24)

Net cash (outflow) / inflow from operating activities

(1,532)

(401)

2,058

 

 

 

5. Related party transactions

 

The related party transactions that occurred in the six months ended 30 September 2017 are not materially different in size or nature to those reported in the Company's Annual Report for the year ended 31 March 2017.

 

6. Availability of Interim Report

 

The Interim Report is being made available to shareholders on the company website www.creightonsplc.com. Further copies can be obtained from the Company's Registered Office, 1210 Lincoln Road, Peterborough, PE4 6ND.

 

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014

 

 

For more information:

 

Nicholas O'Shea, Director, Creightons plc 01733 281000

 

Roland Cornish, Beaumont Cornish Limited 0207 628 3396

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR BBBATMBBTBPR
Date   Source Headline
29th Oct 20215:26 pmRNSDirector/PDMR Shareholding
29th Oct 20213:53 pmRNSDirector/PDMR Shareholding
28th Oct 202111:24 amRNSDirector/PDMR Shareholding
22nd Oct 20217:00 amRNSDirector/PDMR Shareholding, Total Voting Rights
21st Oct 20217:00 amRNSDirector/PDMR Shareholding
5th Oct 20213:57 pmRNSDirector/PDMR Shareholding
5th Oct 20213:51 pmRNSDirector/PDMR Shareholding
4th Oct 20219:12 amRNSTotal Voting Rights
30th Sep 20216:29 pmRNSListing Application
27th Sep 20217:00 amRNSAcquisition of Brodie and Stone
20th Sep 20214:41 pmRNSSecond Price Monitoring Extn
20th Sep 20214:36 pmRNSPrice Monitoring Extension
17th Sep 20217:00 amRNSBlock listing Interim Review
3rd Sep 20219:30 amRNSTotal Voting Rights
26th Aug 202111:19 amRNSFinal Dividend Declaration
25th Aug 20211:34 pmRNSResults of AGM, Final Dividend Declaration
4th Aug 20211:47 pmRNSEmma Hardie Ltd - Q&A video available
29th Jul 20217:00 amRNSAcquisition of Emma Hardie Limited and TVR
21st Jul 20212:05 pmRNSSecond Price Monitoring Extn
21st Jul 20212:00 pmRNSPrice Monitoring Extension
21st Jul 202111:05 amRNSSecond Price Monitoring Extn
21st Jul 202111:00 amRNSPrice Monitoring Extension
21st Jul 20219:05 amRNSSecond Price Monitoring Extn
21st Jul 20219:00 amRNSPrice Monitoring Extension
21st Jul 20217:00 amRNSPreliminary Results - for year ended 31 March 2021
20th Jul 20214:17 pmRNSNotice of Results and Presentation
6th Jul 20213:24 pmRNSUpdate on Notice of Final Results
24th Jun 20217:00 amRNSPresentation on Final Results
26th Mar 202111:35 amRNSChange of Director's Role
18th Mar 20217:00 amRNSBlock Listing Six Monthly Review
16th Mar 202111:42 amRNSShare Option Grant
9th Mar 20219:52 amRNSDirector/PDMR Shareholding
25th Feb 20212:54 pmRNSDirector/PDMR Shareholding
24th Feb 20215:28 pmRNSFurther Statement regarding Innovaderma
24th Feb 20214:46 pmRNSForm 8.3 - Creightons PLC
12th Feb 20212:35 pmRNSForm 8.3 - Creightons
11th Feb 20218:43 amRNSForm 8 (OPD) Creightons plc
5th Feb 20215:15 pmRNSForm 8.3 - Creightons plc
4th Feb 20216:28 pmRNSRule 2.9 Announcement
4th Feb 20215:37 pmRNSForm 8 (OPD) CREIGHTONS
3rd Feb 202112:14 pmGNWForm 8.3 - [Creightons plc] - Opening Disclosure - (CGWL)
2nd Feb 202111:41 amRNSStatement re Possible Offer
2nd Feb 20217:00 amRNSStatement regarding Innovaderma plc
9th Dec 20207:00 amRNSHalf-year Report
24th Nov 20209:28 amRNSChange of Auditor
24th Nov 20209:19 amRNSInterim Results Presentation
30th Sep 20205:39 pmRNSResult of AGM
18th Sep 202011:37 amRNSBlock listing Interim Review
16th Sep 202011:49 amRNSHolding(s) in Company
8th Sep 20205:47 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.